Drugs / Formulation C
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03572062 | Jun 2018 → Jun 2020 | respiratory tract infectious disorder | Pfizer | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Formulation C | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03572062 ↗ |